BARBARA O'CALLAGHAN: Open Payments
NPI 1003041104 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 43 payments from 22 companies in 2025. Trend: 2023 $2,011 · 2024 $1,615 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Daiichi Sankyo Inc. | 4 | $93 |
| Genentech USA, Inc. | 3 | $76 |
| PFIZER INC. | 3 | $72 |
| GENZYME CORPORATION | 2 | $66 |
| SOBI, INC | 2 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $60 |
| Tempus AI, Inc | 2 | $57 |
| Stemline Therapeutics Inc. | 2 | $55 |
Products named: Enhertu, KEYTRUDA, XT CDX, Orserdu, IBRANCE, QINLOCK, PLUVICTO, SARCLISA.
Industry payments across GA — which companies pay providers there.
